|
CPSF2 expression based on
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.491200E-01 |
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 4 samples. One sample from American Indian patient is not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.458000E-01 |
| Normal-vs-AfricanAmerican |
8.640000E-01 |
| Normal-vs-Asian |
7.686400E-01 |
| Caucasian-vs-AfricanAmerican |
9.211800E-01 |
| Caucasian-vs-Asian |
3.297000E-01 |
| AfricanAmerican-vs-Asian |
4.606400E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.117800E-01 |
| Normal-vs-Female |
8.801000E-01 |
| Male-vs-Female |
6.903800E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Four samples from patients aged below 21 are not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.544400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.563000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.809800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.004600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.133200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.270000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.359630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.380000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.408100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.986200E-02 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Paraganglioma |
8.481600E-01 |
| Normal-vs-Pheochromocytoma |
8.181600E-01 |
| Normal-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
7.069400E-01 |
| Paraganglioma-vs-Pheochromocytoma |
8.433600E-01 |
| Paraganglioma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
2.357400E-01 |
| Pheochromocytoma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
1.741350E-01 |
|
|
